TEVA PHARMACEUTICAL INDUSTRIES LIMITED: capex
| Value | {"amount": 165000000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2010-01-01 – 2010-03-31 |
| Status | current |
| Entity | TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:10:44.680477+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3d778cf4-643f-403c-a3ee-c27e1a0b7242
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-10-106539 · Open the official SEC filing →Retrieved: 2026-08-19T08:10:44.680477+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000818686/capex/2010-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3d778cf4-643f-403c-a3ee-c27e1a0b7242
History
- no predecessors — first report